Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Centessa Pharmaceuticals (CNTA) Other Non Operating Income: 2022-2025

Historic Other Non Operating Income for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Sep 2025 value amounting to -$1.8 million.

  • Centessa Pharmaceuticals' Other Non Operating Income fell 149.40% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$33.6 million, marking a year-over-year decrease of 2492.73%. This contributed to the annual value of -$34.1 million for FY2024, which is 528.17% down from last year.
  • Latest data reveals that Centessa Pharmaceuticals reported Other Non Operating Income of -$1.8 million as of Q3 2025, which was down 150.39% from $3.6 million recorded in Q2 2025.
  • Centessa Pharmaceuticals' 5-year Other Non Operating Income high stood at $5.4 million for Q2 2022, and its period low was -$36.4 million during Q4 2024.
  • Over the past 3 years, Centessa Pharmaceuticals' median Other Non Operating Income value was -$1.3 million (recorded in 2023), while the average stood at -$3.3 million.
  • As far as peak fluctuations go, Centessa Pharmaceuticals' Other Non Operating Income slumped by 4,043.28% in 2024, and later soared by 2,232.47% in 2025.
  • Centessa Pharmaceuticals' Other Non Operating Income (Quarterly) stood at -$70,000 in 2022, then plummeted by 1,154.29% to -$878,000 in 2023, then tumbled by 4,043.28% to -$36.4 million in 2024, then slumped by 149.40% to -$1.8 million in 2025.
  • Its Other Non Operating Income was -$1.8 million in Q3 2025, compared to $3.6 million in Q2 2025 and $1.0 million in Q1 2025.